Module III On-Demand 2023

join the leaders in advanced anti-aging medicine

Neuropsychiatric and neurodegenerative disorders are at an all-time high and one of the leading causes of disability worldwide. This Neurology module details the neuropsychological components of a systems biology approach to the brain and peripheral nervous systems. For example, recent developments in psychoneuroimmunology and the Gut-Neuro-Endocrine axis have defined the critical relationships between the brain and all bodily systems at the cellular and sub-cellular levels. The role of neuroinflammation and its relation to microbes, metals and other exposures on brain health will also be explored. Cutting edge treatments such as lipid therapy, the Bredesen Protocol, hyperbaric oxygen treatment, peptides, nutritional approaches, and regenerative therapies will be covered.

objectives

Recognize the parameters within the Functional Medicine Matrix that would indicate the need for attention to neurotransmitter function
Discuss the role of early child-hood trauma on the physiological functions of the Neuro-Endocrine-Immune system
Describe the role of microbes, metals, and other exposures on the development of neurological disorders
Examine the role of neuroinflammation in neurodegenerative and neuropsychiatric conditions.
Discuss cutting edge anti-aging and functional medicine treatment modalities in common neurological disorders
Explore cutting edge modalities in neurotransmitter and other advanced biomarker and genetic testing and understanding their functional roles in behavior and neurological conditions

Discuss advanced neuroendocrine immune testing methods to identify early treatment intervention, and order of treatment to optimize neurodevelopmental and neurocognitive outcome in the complicated patient
Identify clinical tools underlying inflammatory conditions which can result in misdiagnosis and treatment of psychiatric and neurological disorders
Review the basics of neuroimaging in identifying its impact on affective mood disorders and predicting potential psychopathology in the high risk clinical patient
Differentiation of ADD as a genetic disorder and the impact of additional neurocognitive variables such as brain injury, sports concussion, sleep deprivation and sleep disordered breathing/sleep apnea.
Identification of the different symptom clusters that emerge with specific developmental time periods (early elementary, junior high, high school, college, adult, aging) resulting in specific emotional and neurocognitive concerns.